M RN4 Pill - blue round
Pill with imprint M RN4 is Blue, Round and has been identified as Risperidone (Orally Disintegrating) 4 mg. It is supplied by Mylan Pharmaceuticals Inc.
Risperidone is used in the treatment of Autism; Asperger Syndrome; Schizoaffective Disorder; Bipolar Disorder; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Risperidone 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M RN4
Risperidone (Orally Disintegrating)
- Imprint
- M RN4
- Strength
- 4 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6047 (Discontinued)
- Inactive Ingredients
-
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer,
aspartame,
FD&C Blue No. 1,
FD&C Yellow No. 6,
magnesium stearate,
mannitol,
lactose monohydrate,
silicon dioxide,
sodium lauryl sulfate,
sodium stearyl fumarate,
sorbitol,
stearic acid
Note: Inactive ingredients may vary.
Related images for "M RN4"
More about risperidone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (735)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Risperidone drug information
- Risperidone injection
- Risperidone (Intramuscular, Subcutaneous) (Advanced Reading)
- Risperidone Orally Disintegrating Tablets
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, ... +2 more
Professional resources
- Risperidone monograph
- Risperidone (FDA)
- Risperidone Injection (FDA)
- Risperidone Oral Solution (FDA)
- Risperidone Orally Disintegrating (FDA)
Other brands
Risperdal, Uzedy, Risperdal Consta, Perseris, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.